The US FDA Advisory Committee Surge Is Finally Here

 
• By Michael McCaughan

The US FDA will have “a lot more advisory committees in 2023,” the head of the agency’s drug center says. The numbers back her up.

PS2304_advisory_committee_surge
CDER wants to make it easier for review teams to have advisory committee meetings. • Source: Nielsen Hobbs; the Pink Sheet | Shutterstock images

More from US FDA Performance Tracker

More from Regulatory Trackers